Autres langues Tristel plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:15 29/04/2024			Varia. 5j.	Varia. 1 janv.
470 ^GBX	-2,08%		+5,62%	+2,17%

18/04	Paul Swinney, PDG de Tristel, vend pour 230 000 GBP d'actions	AN
26/02	Le système de désinfection sporicide de Tristel reçoit une recommandation positive des régulateurs au Royaume-Uni et dans l'Union européenne	MT

Tristel CEO Paul Swinney sells GBP230,000 in shares	18/04
Tristel doubles dividend on revenue and profit boost in first half	26/02
Tristel's Sporicidal Disinfectant System Receives Positive Recommendation from Regulators in UK, EU	26/02
Tristel plc Recommends Interim Dividend, Payable on 12 April 2024	26/02
Tristel plc Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Tristel gets approval in Canada for ULT ultrasound disinfectant device	23/01
Tristel Receives Canadian Approval for Disinfectant Device	23/01
Tristel plc Announces Canadian Regulatory Approval for Tristel Ult as a high-level disinfectant	23/01
Tristel optimistic of strong second half following good start to year	19/12
Paul Swinney Intends to Retire as Group CEO of Tristel plc	19/12
Tristel plc Provides Revenue Guidance for the Six Months Ending December 31, 2023	19/12
FTSE 100 Closes Up Supported by Basic Resources, Energy Stocks	16/10/23
Tristel's annual profit multiplies; outlook "strongest" in 30 years	16/10/23
Earnings Flash (TSTL.L) TRISTEL Posts FY23 Revenue GBP36M	16/10/23
Tristel plc Recommends Final Dividend, Payable on 22 December 2023	16/10/23
Tristel plc Reports Earnings Results for the Full Year Ended June 30, 2023	16/10/23
FTSE 100 to rise as oil consolidates gains	16/10/23
Stocks red as rate fears weigh on investors	13/10/23
Stocks lower as conflict and rate fears weigh	13/10/23
Tristel submits to Health Canada for Tristel ULT medical approval	04/09/23

Aucun résultat pour cette recherche